DE3877331T2 - Exifon und ein wasserloesliches polymer enthaltende pharmazeutische zubereitung. - Google Patents

Exifon und ein wasserloesliches polymer enthaltende pharmazeutische zubereitung.

Info

Publication number
DE3877331T2
DE3877331T2 DE8888118627T DE3877331T DE3877331T2 DE 3877331 T2 DE3877331 T2 DE 3877331T2 DE 8888118627 T DE8888118627 T DE 8888118627T DE 3877331 T DE3877331 T DE 3877331T DE 3877331 T2 DE3877331 T2 DE 3877331T2
Authority
DE
Germany
Prior art keywords
water
soluble polymer
exifon
pharmaceutical preparation
polymer containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888118627T
Other languages
English (en)
Other versions
DE3877331D1 (de
Inventor
Yoshio Ueda
Fumio Shimojo
Mitsuru Yasumura
Kenzo Toyoshima
Nobumitsu Nakahashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Pharmascience SA
Original Assignee
Laboratoires Pharmascience SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Pharmascience SA filed Critical Laboratoires Pharmascience SA
Publication of DE3877331D1 publication Critical patent/DE3877331D1/de
Application granted granted Critical
Publication of DE3877331T2 publication Critical patent/DE3877331T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
DE8888118627T 1987-11-11 1988-11-09 Exifon und ein wasserloesliches polymer enthaltende pharmazeutische zubereitung. Expired - Fee Related DE3877331T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28449387 1987-11-11

Publications (2)

Publication Number Publication Date
DE3877331D1 DE3877331D1 (de) 1993-02-18
DE3877331T2 true DE3877331T2 (de) 1993-05-27

Family

ID=17679231

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888118627T Expired - Fee Related DE3877331T2 (de) 1987-11-11 1988-11-09 Exifon und ein wasserloesliches polymer enthaltende pharmazeutische zubereitung.

Country Status (8)

Country Link
US (1) US5093372A (de)
EP (1) EP0315964B1 (de)
KR (1) KR0132571B1 (de)
AT (1) ATE84213T1 (de)
CA (1) CA1319110C (de)
DE (1) DE3877331T2 (de)
ES (1) ES2043766T3 (de)
PH (1) PH26518A (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2640137A1 (fr) * 1988-12-08 1990-06-15 Texinfine Sa Systemes transporteurs de principes actifs lipophiles et leur procede d'obtention
EP0489181B1 (de) * 1990-07-19 1996-10-02 Otsuka Pharmaceutical Co., Ltd. Feste zusammensetzung
US5977077A (en) * 1995-08-28 1999-11-02 Interlab Corporation Xanthone analogs for the treatment of infectious diseases
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
CN1211928A (zh) * 1996-11-04 1999-03-24 联合碳化化学品及塑料技术公司 提高基本不溶于水的化合物溶解度的方法
TW486370B (en) * 1996-12-25 2002-05-11 Yamanouchi Pharma Co Ltd Rapidly disintegrable pharmaceutical composition
US6964779B1 (en) 1998-04-08 2005-11-15 Kyowa Hakko Kogyo Co., Ltd. Tablet manufacturing method and tablet
WO2001041773A1 (en) 1999-12-02 2001-06-14 Interlab, Inc. Xanthone analogs for treating infectious diseases and complexation of heme and porphyrins
JP2003518485A (ja) 1999-12-23 2003-06-10 ファイザー・プロダクツ・インク 向上された薬物濃度を与える医薬組成物
MXPA03011935A (es) * 2001-06-22 2004-03-26 Pfizer Prod Inc Composiciones farmaceuticas que contienen conjuntos de polimero y farmaco.
EP1269994A3 (de) * 2001-06-22 2003-02-12 Pfizer Products Inc. Pharmazeutische Zusammensetzungen die ein Arzneimittel und die Konzentration verbesserende Polymere enthalten
AU2003301121A1 (en) * 2002-12-18 2004-07-14 Pain Therapeutics, Inc. Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EP2110464B1 (de) * 2007-01-31 2015-08-12 Asahi Glass Company, Limited Ionenaustauschmembran für die alkalichlorid-elektrolyse
CN106138018B (zh) * 2015-04-02 2020-03-13 广州洁成生物科技有限公司 羟基二苯甲酮在制备抗病毒和抗肿瘤药物中的应用
AU2016369642A1 (en) * 2015-12-17 2018-08-02 Massachusetts Institute Of Technology Compositions of polyhydroxylated benzophenones and methods of treatment of neurodegenerative disorders
US11433051B2 (en) 2016-02-16 2022-09-06 Siga Technologies, Inc. ST-246 (tecovirimat monohydrate) suspension formulations
US11517548B2 (en) * 2018-07-19 2022-12-06 Impel Pharmaceuticals Inc. Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's Disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1492034A1 (de) * 1965-05-18 1969-02-20 Merck Ag E Verfahren zur Herstellung fester haltbarer Zubereitungen von empfindlichen,in Wasser schwer loeslichen Wirkstoffen,vorzugsweise Arzneimitteln
JPS5439445B2 (de) * 1973-03-24 1979-11-28
FR2257272B1 (de) * 1974-01-15 1978-08-25 Pharmascience Labo
FR2377202A2 (fr) * 1977-01-12 1978-08-11 Pharmascience Lab Compositions pharmaceutiques contenant de l'hexahydroxy-2,3,4,3',4',5'-benzophenone
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
US4145440A (en) * 1977-08-18 1979-03-20 The Upjohn Company Liquid suspension of an aluminum salt of ibuprofen
JPS6038322A (ja) * 1983-08-11 1985-02-27 Fujisawa Pharmaceut Co Ltd ジヒドロピリジンａ物質含有易溶性固形製剤
GB8608080D0 (en) * 1986-04-02 1986-05-08 Fujisawa Pharmaceutical Co Solid dispersion composition

Also Published As

Publication number Publication date
US5093372A (en) 1992-03-03
PH26518A (en) 1992-08-07
EP0315964B1 (de) 1993-01-07
DE3877331D1 (de) 1993-02-18
EP0315964A1 (de) 1989-05-17
KR0132571B1 (ko) 1998-04-17
KR890007722A (ko) 1989-07-05
ES2043766T3 (es) 1994-01-01
CA1319110C (en) 1993-06-15
ATE84213T1 (de) 1993-01-15

Similar Documents

Publication Publication Date Title
DE3877331T2 (de) Exifon und ein wasserloesliches polymer enthaltende pharmazeutische zubereitung.
DE69019817D1 (de) Trägermaterial zur Arzneimittelverabreichung.
FR2633181B1 (fr) Composition pharmaceutique a base de ranitidine et son procede de preparation
ES548168A0 (es) Procedimiento para preparar composiciones de uso cosmetico o farmaceutico a base de unas esferulas lipidicas que contienen un polimero de poliamida.
FI881978A (fi) Menetelmä eperisonia sisältävän farmaseuttisen koostumuksen valmistamiseksi
ATA315488A (de) Neue adenosinderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische praeparate
IT8721411A0 (it) Composizione farmaceutica idrosolubile contenente n acetilsisteina.
DE3677842D1 (de) Verfahren zur herstellung von piperidyliden-dihydrodibenzo(a,d)zykloheptenen und deren azoderivate, so hergestellte verbindungen und ihre anwendung zur vorbereitung von heilmitteln.
DE69007714D1 (de) Pharmazeutische Zubereitung mit antitumoraler Wirkung und Verfahren zur Herstellung.
DE3777122D1 (de) Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE69012650D1 (de) Piperidinderivat, Verfahren zur Herstellung davon und dieses enthaltende pharmazeutische Zusammensetzung.
DE3887068D1 (de) 2,2-Dimethylchromenderivate, Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
EP0416575A3 (en) Drug delivery compositions based on biological materials and methods for preparing such compositions
DE3852332D1 (de) 4-Thiochinazolin-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammenstellungen.
DK0443848T3 (da) Nyt antiulcermiddel
DE3767894D1 (de) 1,2-dithiol-3-thion-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung.
ATA146488A (de) 2-methoxymethylpenemverbindungen, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
IT8805224A0 (it) Composizione a base di poliesteri per la liberazione controllata di sostanze medicamentose.
DK0400637T3 (da) Præparat indeholdende FR115224-substans til parenteral administration
ATE57935T1 (de) 16,17-acetalsubstituierte pregnan-21-saeure, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.
DE3772687D1 (de) Arzneimittel zur heilung von arteriosklerose, enthaltend ein pyrimido(2,1-b)benzothiazol-derivat.
DE3888697T2 (de) 2,3-thiomorpholinedion-2-oxim-derivate, arzneimittelzusammensetzungen und verfahren zur herstellung.
FR2648710B1 (fr) Composition pharmaceutique a base de ranitidine et son procede de preparation
DE58902310D1 (de) Tetrahydropyridin-derivate.
DK101781A (da) Fremgangsmaade til fremstilling af 10/substituerede 5-cyamethylen-dibenzo (a,d) cycloheptener

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee